The duration of effect of infliximab maintenance treatment in paediatric Crohn's disease is limited.
De Bie CI; Hummel TZ; Kindermann A; Kokke FT; Damen GM; Kneepkens CM; Van Rheenen PF; Schweizer JJ; Hoekstra JH; Norbruis OF; Tjon A Ten WE; Vreugdenhil AC; Deckers-Kocken JM; Gijsbers CF; Escher JC; De Ridder L; Alimentary Pharmacology & Therapeutics, 2011, vol. 33, issue 2, p 243, ISSN 13652036. ISBN 13652036.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef